Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Feb 14, 2025 · 10-K · 45 days after period end · 0000950170-25-020467
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $3.67M |
| Net Income | -$6.31M | -$5.90M | -$4.64M | -$6.27M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 14, 2025 · 45 d after period end
